Is N-terminal pro-brain natriuretic peptide superior to clinical scores for risk stratification in non-massive pulmonary embolism?

被引：8
|
作者：
Vuilleumier, N. [1 ,2 ]
Le Gal, G. [3 ]
Cornily, J. C. [3 ]
Hochstrasser, D. [1 ,2 ]
Bounameaux, H. [2 ,4 ]
Aujesky, D. [5 ]
Righini, M. [2 ,4 ]
机构：
[1] Univ Hosp Geneva, Dept Genet & Lab Med, Div Lab Med, Geneva, Switzerland
[2] Univ Geneva, Geneva, Switzerland
[3] Brest Univ Hosp, EA GETBO 3878, Dept Med & Chest Dis, Brest, France
[4] Univ Hosp Geneva, Dept Internal Med, Div Angiol & Haemostasis, Geneva, Switzerland
[5] Univ Lausanne, Div Gen Internal Med, Lausanne, Switzerland
来源：
JOURNAL OF THROMBOSIS AND HAEMOSTASIS | 2010年 / 8卷 / 06期
关键词：
MOLECULAR-WEIGHT HEPARIN; DIAGNOSIS;
D O I：
10.1111/j.1538-7836.2010.03879.x
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1433 / 1435
页数：4
相关论文
共 50 条
  • [31] Levels of N-terminal pro-brain natriuretic peptide in brain injury patients
    L Tsentsiper
    E Kondratyeva
    S Kondratyev
    N Dryagina
    Critical Care, 19 (Suppl 1):
  • [32] Plasma N-terminal pro-brain natriuretic peptide and brain natriuretic peptide in assessment of acute dyspnea
    Alibay, Y
    Beauchet, A
    El Mahmoud, R
    Schmitt, C
    Brun-Ney, D
    Benoit, MO
    Dubourg, O
    Boileau, C
    Jondeau, G
    Puy, H
    BIOMEDICINE & PHARMACOTHERAPY, 2005, 59 (1-2) : 20 - 24
  • [33] Repeated measurements of N-terminal pro-brain natriuretic peptide enable dynamic risk stratification in critically ill patients
    B Meyer
    M Hülsmann
    P Wexberg
    M Nikfardjam
    G Strunk
    T Szekeres
    G Gouya
    R Pacher
    G Heinz
    Critical Care, 13 (Suppl 1):
  • [34] Can plasma levels of N-terminal pro-brain natriuretic peptide be useful in predicting the risk of developing chronic pulmonary hypertension in patients with pulmonary embolism?
    Lussana, Federico
    Podda, Gian Marco
    Cattaneo, Marco
    INTERNAL AND EMERGENCY MEDICINE, 2009, 4 (05) : 443 - 444
  • [35] Can plasma levels of N-terminal pro-brain natriuretic peptide be useful in predicting the risk of developing chronic pulmonary hypertension in patients with pulmonary embolism?
    Federico Lussana
    Gian Marco Podda
    Marco Cattaneo
    Internal and Emergency Medicine, 2009, 4 : 443 - 444
  • [36] Urinary N-terminal Pro-Brain Natriuretic Peptide in Newborn Infants with Cardiac and Pulmonary Diseases
    Elgendy, Marwa M.
    Elzayat, Rania Salah
    Abdo, Mostafa
    Elsharkawy, Hamed M.
    Allam, Maha
    Midan, Dina Abdelrazek
    AMERICAN JOURNAL OF PERINATOLOGY, 2024, 41 (01) : 53 - 59
  • [37] Exercise Dependence of N-Terminal Pro-Brain Natriuretic Peptide in Patients with Precapillary Pulmonary Hypertension
    Grachtrup, Sabine
    Bruegel, Mathias
    Pankau, Hans
    Halank, Michael
    Wirtz, Hubert
    Seyfarth, Hans-Juergen
    RESPIRATION, 2012, 84 (06) : 454 - 460
  • [38] N-terminal pro-brain natriuretic peptide and renal insufficiency as predictors of mortality in pulmonary hypertension
    Leuchte, Hanno H.
    El Nounou, Michal
    Tuerpe, Juergen Christian
    Hartmann, Bertram
    Baumgartner, Rainer A.
    Vogeser, Michael
    Muehling, Olaf
    Behr, Juergen
    CHEST, 2007, 131 (02) : 402 - 409
  • [39] No firm association between N-terminal pro-brain natriuretic peptide and percentage of pulmonary vascular obstruction in patients with acute pulmonary embolism
    Agterof, M. J.
    Schutgens, R. E. G.
    Verzijlbergen, J. F.
    van Buul, M. M. C.
    Tromp, E. A. M.
    Eijkemans, M. J. C.
    van der Griend, R.
    Biesma, D. H.
    THROMBOSIS RESEARCH, 2011, 127 (06) : 547 - 550
  • [40] N-terminal pro-brain natriuretic peptide levels and risk of death in sickle cell disease
    Machado, Roberto F.
    Anthi, Anastasia
    Steinberg, Martin H.
    Bonds, Duane
    Sachdev, Vandana
    Kato, Gregory J.
    Taveira-DaSilva, Angelo M.
    Ballas, Samir K.
    Blackwelder, William
    Xu, Xiuli
    Hunter, Lori
    Barton, Bruce
    Waclawiw, Myron
    Castro, Oswaldo
    Gladwin, Mark T.
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2006, 296 (03): : 310 - 318
12345